ISSN: 2320-480X
Manuscript Submission

The Journal of Phytopharmacology, 2020;9(2):130-138 ;   DOI:10.31254/phyto.2020.9210

Review Article

Use of Orchids in treating Diabetes and related diseases: A review

Sourav Mukherjee1 , Suresh Jagtap2

1. Biology Faculty, PACE IIT and Medicals, Satara, Maharashtra, India
2. Interactive Research School for Health Affairs, Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India

*Author to whom correspondence should be addressed.

Received: 26th February, 2020 / Accepted: 10th March, 2020

Abstract


Diabetes is one of the most common diseases and is one of the main causes of morbidity and mortality in world. The number of diabetic patients showed a sharp rise from 347 million to 400 million in seven years (2008 to 2015). India is one of the frontrunner countries in harbouring this disease. Herbal drugs are always been intriguing for the treatment of diabetes. Several polyherbal formulations, single drugs have been assigned to possess anti-diabetic potentials. Among the plant families, Orchidaceae is not only one of the most interesting, also have been praised for their medicinal values since ages. This review tries to encompass the uses of orchids in diabetes and related disorders. Nearly 19 species belonging to 12 genera of orchids are traditionally used in treating Diabetes and related pathophysiological conditions across the Globe. Some of them, if validation is concerned, are proven experimentally to show anti-diabetic and antihyperglycaemic potentials on standard animal models. Pharmacological studies revealed that as many as 17 species included in 6 genera of orchids are evaluated so far for anti-diabetic potential. With forbidden gaps in the traditional belief and pharmacological profile currently, there remains indeed a potential area for bio-prospecting of orchid group for their ant-diabetic property.

Keywords

Orchids, Traditional Medicine, Diabetes, Hyperglycaemia.


HOW TO CITE THIS ARTICLE

Mukherjee S, Jagtap S. Use of Orchids in treating Diabetes and related diseases: A review. J Phytopharmacol 2020; 9(2):130-138.

Creative Commons (CC) License-

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).

Copyright

Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.

Technical Support

×